The Bill & Melinda Gates Foundation announced Thursday its support for “a narrow waiver” of intellectual property protections for Covid-19 vaccines—a shift from the foundation’s previous stance on the issue that comes amid sustained scrutiny over Big Pharma’s role in blocking such a move.
Foundation CEO Mark Suzman’s statement, reported first by Devex, came a day after the Biden administration—in the face of global pressure—announced its support for a TRIPS waiver proposal at the World Trade Organization.
In his remarks, Suzman pointed to “heartbreaking surges in India and Brazil” and said “there’s much more to be done” to increase vaccine access.
“No barriers should stand in the way of equitable access to vaccines, including intellectual property,” he added, “which is why we are supportive of a narrow waiver during the pandemic.”
Click Here: Argentina Rugby Shop
The announcement come less than three weeks after billionaire Bill Gates, co-chair and trustee of the foundation that bears his name, said in an interview with Sky News that he was against sharing vaccine recipes with the world as a way to stem the global crisis.
Musing on the possible motive behind the change in the foundation’s position on patent waivers, Health Global Access Project on Friday attributed the reversal to when “you see history being written and realize you’re on the wrong side of it.”
Journalist Adam H. Johnson responded to Suzman’s statement with a Twitter thread saying that the prospect of a “narrow” waiver was worthy of scrutiny and suggested it was a sign of corporate interests moving “to coopt the patent waiver debate and make sure it’s as watered down and temporary as possible.”
SCROLL TO CONTINUE WITH CONTENT